| | | | | |
| $13,8100 | +0,00 % | $244,14M | $769,25K | |
REFI Chicago Atlantic Real Estate Finance, Inc. Common Stock | $11,4100 | +0,00 % | $244,04M | $225,07K | |
GTERA Globa Terra Acquisition Corporation Class A Ordinary Shares | $10,3200 | +0,00 % | $243,91M | $4,000 | |
NUS NuSkin Enterprises, Inc. | $5,2800 | +0,00 % | $243,72M | $758,37K | |
FHTX Foghorn Therapeutics Inc. Common Stock | $4,2300 | +0,24 % | $243,66M | $291,97K | |
FATE Fate Therapeutics, Inc. | $2,1000 | +0,00 % | $243,60M | $3,93M | |
| $13,4400 | +0,07 % | $242,53M | $236,27K | |
VABK Virginia National Bankshares Corporation Common Stock | $46,2500 | +1,60 % | $242,44M | $7,33K | |
SCM STELLUS CAPITAL INVESTMENT CORPORATION | $8,4300 | +0,00 % | $241,70M | $183,59K | |
IKT Inhibikase Therapeutics, Inc. Common Stock | $1,8900 | -1,05 % | $241,61M | $685,93K | |
ARL American Realty Investors, Inc. | $19,9000 | -7,44 % | $240,82M | $7,94K | |
RAAQ Real Asset Acquisition Corp. Class A Ordinary Share | $10,5700 | -0,09 % | $240,81M | $215,89K | |
MCGA Yorkville Acquisition Corp. Class A Ordinary Share | $10,2250 | +0,15 % | $240,52M | $18,20K | |
DHY Credit Suisse High Yield Credit Fund | $1,7500 | +0,00 % | $240,37M | $573,13K | |
SOCA Solarius Capital Acquisition Corp. Class A Ordinary Share | $10,2600 | -0,20 % | $240,36M | $2,000 | |
